Skip to main content

Adjuvant Metastatic Urothelial Cancer CA244-0012 IZABRIGHT-Bladder01

Status: Closed to Enrollment

Study details

View study details on clinicaltrials.gov.

Locations

  • Sacramento
  • Palo Alto
  • Santa Rosa

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

TEMPORARILY CLOSED TO ENROLLMENT

IZABRIGHT-Bladder01: A Randomized, Open-label, Phase 2/3 Trial of Izalontamab Brengitecan Versus Platinum-based Chemotherapy for Metastatic Urothelial Cancer in Participants With Disease Progression on or After an Immunotherapy-based Treatment

Nitin Rohatgi, M.D., MBA
Nitin Rohatgi, M.D., MBA
Principal investigator
View profile

Sub-Investigators

Ari D Baron, M.D., Zeyad H Kanaan, M.D., Roozbeh Mohajer, M.D.

Related clinical trials

View all clinical trials
  • Clinical trial

    Muscle-Invasive Bladder Cancer EV-309

    A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE ENFORTUMAB VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB IN ADULT PARTICIPANTS WITH MUSCLE-INVASIVE BLADDER CANCER WHO ARE INELIGIBLE FOR OR HAVE ELECTED NOT TO UNDERGO CYSTECTOMY

    Status: Open to Enrollment

  • Clinical trial

    Advanced Cervical Cancer NRG GY037

    A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer

    Status: Open to Enrollment

  • Clinical trial

    Advanced Staged Cancer Targeted Therapy ASCO TAPUR

    Targeted Agent and Profiling Utilization Registry (TAPUR) Study

    Status: Open to Enrollment

  • Clinical trial

    Adverse Effects of Chemotherapy Shengbai Solution

    A Randomized, Blinded, Placebo-controlled Trial of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Patients With Cancer Undergoing Chemotherapy

    Status: Open to Enrollment

  • Clinical trial

    Acute Myeloid Leukemia Dental Wipes COG ACCL2531

    A Randomized Double-Blinded Trial of Xylitol Dental Wipes for the Prophylaxis of Bloodstream Infections From Oral Organisms in Pediatric Patients With Acute Myeloid Leukemia

    Status: Open to Enrollment

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?